Skip to main content
SpringerLink
Log in

Paraoxonase (PON1) activity in patients with subclinical thoracic aortic atherosclerosis

  • Original Paper
  • Published:
The International Journal of Cardiovascular Imaging Aims and scope Submit manuscript

Abstract

High density lipoprotein (HDL), a powerful antioxidant, protects low density lipoprotein (LDL) particles against oxidative stress. By limiting LDL oxidation, HDL plays an important role in preventing atherosclerosis (AS). The antioxidant effect of HDL is mostly associated with the paraoxonase (PON1) activity. It has been known that increased aortic intima-media thickness (IMT) is an earlier marker AS than carotid IMT. We aimed to investigate the association between thoracic aortic IMT and serum PON1 activity. We studied 133 patients (mean age: 46.3 ± 8 years) who underwent transesophageal echocardiography (TEE) for various indications. The measurements of thoracic aortic IMT by TEE are classified into four grades (1, 2, 3 and 4). Serum PON1 activity was measured spectrophotometrically. Oxidative and anti-oxidative status was evaluated by measuring serum lipid hydroperoxide (LOOH), total anti-oxidant status (TAS). Serum PON1 activity was progressively decreasing from grade 1 IMT to grade 4 IMT (p < 0.001). However, serum LOOH was significantly lower and TAS was significantly higher in patients with grade 1 when compared with other grades. In multiple linear regression analysis, IMT was independently correlated with PON1 activity (β = −0.495, p < 0.001), TAS level (β = −196, p < 0.009), age (β = 0.145, p = 0.029) and LDL cholesterol level (β = 0.169, p = 0.009). Decreased PON1 activity was independently associated with the extent of thoracic AS. PON1 activity may play a role in pathogenesis of thoracic AS besides age, TAS and LDL cholesterol levels.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Barter PJ, Nicholls S, Rye KA et al (2004) Antiinflammatory properties of HDL. Circ Res 95:764–772

    Article  CAS  PubMed  Google Scholar 

  2. Mineo C, Deguchi H, Griffin JH et al (2006) Endothelial and antithrombotic actions of HDL. Circ Res 98:1352–1364

    Article  CAS  PubMed  Google Scholar 

  3. Mackness MI, Durrington PN, Mackness B (2000) How high-density lipoprotein protects against the effects of lipid peroxidation. Curr Opin Lipidol 11:383–388

    Article  CAS  PubMed  Google Scholar 

  4. Soran H, Younis NN, Charlton-Menys V et al (2009) Variation in paraoxonase-1 activity and atherosclerosis. Curr Opin Lipidol 20:265–274

    Article  CAS  PubMed  Google Scholar 

  5. Soran H, Hama S, Yadav R, Durrington PN (2012) HDL functionality. Curr Opin Lipidol 23:353–366

    Article  CAS  PubMed  Google Scholar 

  6. Mackness MI, Arrol S, Abbott C et al (1993) Protection of low-density lipoprotein against oxidative modification by high density lipoprotein associated paraoxonase. Atherosclerosis 104:129–135

    Article  CAS  PubMed  Google Scholar 

  7. Mackness B, Durrington PN, Mackness MI (2002) The paraoxonase gene family and coronary heart disease. Curr Opin Lipidol 13:357–362

    Article  CAS  PubMed  Google Scholar 

  8. Gur M, Aslan M, Yildiz A et al (2006) Paraoxonase and arylesterase activities in coronary artery disease. Eur J Clin Invest 36:779–787

    Article  CAS  PubMed  Google Scholar 

  9. Sarkar PD, TMS, Madhusudhan B (2006) Association between paraoxonase activity and lipid levels in patients with premature coronary artery disease. Clin Chim Acta 373:77-81

  10. Hung CL, Po HL, Liu CC, Yen CH, Wu YJ, Hou CJ, Kuo JY, Yeh HI, Su S (2013) The utilization of carotid artery imaging beyond metabolic scores and high-sensitivity CRP in screening intermediate-to-high Framingham risk of asymptomatic Taiwanese population. Int J Cardiovasc Imaging 29(4):765–775

    Article  PubMed  Google Scholar 

  11. Ko GT, Chow CC, Leung G, Au-Yeung TW, Chan WB, Lam CS, Lo M, Lee KK (2011) High rate of increased carotid intima-media thickness and atherosclerotic plaques in Chinese asymptomatic subjects with central obesity. Int J Cardiovasc Imaging 27(6):833–841

    Article  CAS  PubMed  Google Scholar 

  12. Tribouilloy C, Shen WF, Peltier M et al (1994) Noninvasive prediction of coronary artery disease by transesophageal echocardiographic detection of thoracic aortic plaque in valvular heart disease. Am J Cardiol 74:258–260

    Article  CAS  PubMed  Google Scholar 

  13. Harrington J, Peña AS, Gent R et al (2010) Aortic intima media thickness is an early marker of atherosclerosis in children with type 1 diabetes mellitus. J Pediatr 156:237–241

    Article  PubMed  Google Scholar 

  14. Teichholz LE, Kreulen T, Herman MV et al (1976) Problems in echocardiographic volume determinations: echocardiographic–angiographic correlations in the presence of absence of asynergy. Am J Cardiol 37:7–11

    Article  CAS  PubMed  Google Scholar 

  15. Eckerson HW, Wyte CM, La Du BN (1983) The human serum paraoxonase/arylesterase polymorphism. Am J Hum Genet 35:1126–1138

    CAS  PubMed Central  PubMed  Google Scholar 

  16. Erel O (2004) A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 37:112–119

    Article  CAS  PubMed  Google Scholar 

  17. Arab K, Steghens JP (2004) Plasma lipid hydroperoxides measurement by an automated xylenol orange method. Anal Biochem 325:158–163

    Article  CAS  PubMed  Google Scholar 

  18. Sentí M, Tomás M, Fitó M et al (2003) Antioxidant paraoxonase 1 activity in the metabolic syndrome. J Clin Endocrinol Metab 88:5422–5426

    Article  PubMed  Google Scholar 

  19. Aviram M, Rosenblat M, Bisgaier CL, Newton RS, Primo-Parmo SL, La Du BN (1998) Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J Clin Invest 101:1581–1590

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  20. Tartan Z, Orhan G, Kasikçioglu H et al (2007) The role of paraoxonase (PON) enzyme in the extent and severity of the coronary artery disease in type-2 diabetic patients. Heart Vessels 22:158–164

    Article  PubMed  Google Scholar 

  21. Demirbag R, Yilmaz R, Kunt AS et al (2006) Relationship between plasma total antioxidant capacity and thoracic aortic intima-media thickness. Echocardiography 23:183–188

    Article  PubMed  Google Scholar 

  22. Serdar Z, Aslan K, Dirican M et al (2006) Lipid and protein oxidation and antioxidant status in patients with angiographically proven coronary artery disease. Clin Biochem 39:794–803

    Article  CAS  PubMed  Google Scholar 

  23. Navab M, Hama SY, Van Lenten BJ et al (1997) Mildly oxidized LDL induced an increased apolipoprotein J/paraoxonase ratio. J Clin Invest 99:2005–2020

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  24. Aviram M, Rosenblat M, Billecke S et al (1999) Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. Free Radic Biol Med 26:892–904

    Article  CAS  PubMed  Google Scholar 

  25. Van Lenten BJ, Navab M, Shih D et al (2001) The role of high-density lipoproteins in oxidation and inflammation. Trends Cardiovasc Med 11:155–161

    Article  PubMed  Google Scholar 

  26. Ansell BJ, Fonarow GC, Fogelman AM (2007) The paradox of dysfunctional high-density lipoprotein. Curr Opin Lipidol 18:427–434

    Article  CAS  PubMed  Google Scholar 

  27. Ansell BJ, Fonarow GC, Fogelman AM (2006) High-density lipoprotein: is it always atheroprotective? Curr Atheroscler Rep 8:405–411

    Article  CAS  PubMed  Google Scholar 

  28. Navab M, Anantharamaiah GM, Fogelman AM (2005) The role of high-density lipoprotein in inflammation. Trends Cardiovasc Med 15:158–161

    Article  CAS  PubMed  Google Scholar 

  29. Novak F, Vavrova L, Kodydkova J et al (2010) Decreased paraoxonase activity in critically ill patients with sepsis. Clin Exp Med 10:21–25

    Article  CAS  PubMed  Google Scholar 

  30. Mackness MI, Mackness B, Durrington PN (2002) Paraoxonase and coronary heart disease. Atheroscler Suppl 3:49–55

    Article  CAS  PubMed  Google Scholar 

  31. Mackness B, Davies GK, Turkie W et al (2001) Paraoxonase status in coronary heart disease. Are activity and concentration more important than genotype? Arterioscler Thromb Vasc Biol 21:1451–1457

    Article  CAS  PubMed  Google Scholar 

  32. Jarvik GP, Rozek LS, Brophy VH et al (2000) Paraoxonase (PON1) phenotype is a better predictor of vascular disease than is PON1(192) or PON1(55) genotype. Arterioscler Thromb Vasc Biol 20:2441–2447

    Article  CAS  PubMed  Google Scholar 

  33. Costa LG, Vitalone A, Cole TB, Furlong CE (2005) Modulation of paraoxonase (PON1) activity. Biochem Pharmacol 69:541–550

    Article  CAS  PubMed  Google Scholar 

  34. Gupta N, Binu KB, Singh S et al (2012) Low serum PON1 activity: an independent risk factor for coronary artery disease in North-West Indian type 2 diabetics. Gene 498:13–19

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

There are no conflicts of interest.

Author information

Authors and Affiliations

  1. Department of Cardiology, Adana Numune Training and Research Hospital, 01170, Adana, Turkey

    Mustafa Gür, Murat Çaylı, Hakan Uçar, Zafer Elbasan, Durmuş Yıldıray Şahin, Nermin Yıldız Koyunsever, Taner Şeker, Caner Türkoğlu & Onur Kaypaklı

  2. Department of Internal Medicine, Mersin State Hospital, Mersin, Turkey

    Mehmet Yavuz Gözükara

  3. Department of Biochemistry, Faculty of Medicine, School of Medicine, Harran University, Sanliurfa, Turkey

    Şahbettin Selek & Nurten Aksoy

Authors
  1. Mustafa Gür
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Murat Çaylı
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hakan Uçar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Zafer Elbasan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Durmuş Yıldıray Şahin
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Mehmet Yavuz Gözükara
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Şahbettin Selek
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Nermin Yıldız Koyunsever
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Taner Şeker
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Caner Türkoğlu
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Onur Kaypaklı
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Nurten Aksoy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mustafa Gür.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gür, M., Çaylı, M., Uçar, H. et al. Paraoxonase (PON1) activity in patients with subclinical thoracic aortic atherosclerosis. Int J Cardiovasc Imaging 30, 889–895 (2014). https://doi.org/10.1007/s10554-014-0407-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10554-014-0407-y

Keywords

Search

Navigation